DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Shirasugi Y, Ando K, Hashino S. , et al.
A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura.
Int J Hematol 2009;
90 (02) 157-165
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.